Dr. Jaeger is President and Principal Scientist at CognitionMetrics which provides consultation to the pharmaceutical industry on the measurement of cognitive and behavioral change in clinical trials for both efficacy and safety. She is also a Professor of Psychiatry and Behavioral Sciences at Albert Einstein College of Medicine. A sought-after KOL and scientific consultant to major pharma companies as well as biotechs and CROs working in neuroscience, she helps companies optimize their clinical development plans, protocol designs, endpoint selection and execution, and interpretation and communication of results to various stakeholders. Having previously served as VP for Clinical Trials at Cogstate and Director, Clinical Development at AstraZeneca, she is an internationally recognized clinical neuropsychologist and pharmaceutical executive.
Dr. Jaeger has published over 65 peer-reviewed journal articles, seven book chapters, and 200+ abstracts. She has delivered numerous conference presentations and invited lectures. She received her Ph.D. in Neuropsychology from Yeshiva University and her MPA from John Jay College of Criminal Justice of The City University of New York.